Rifabutin absorption in the gut unaltered by concomitant administration of didanosine in AIDS patients.

Didanosine (ddI) is currently used in the management of patients infected by the human immunodeficiency virus. Rifabutin (RBT) is being extensively used for prophylaxis against Mycobacterium avium complex (MAC) infections. Due to its acid-labile characteristics, ddI must be administered with a buffe...

全面介紹

書目詳細資料

發表在:	Antimicrob Agents Chemother
Principais autores:	Li, R C, Narang, P K, Sahai, J, Cameron, W, Bianchine, J R
格式:	Artigo
語言:	Inglês
出版:	American Society for Microbiology (ASM) 1997
主題:	Research Article
在線閱讀:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163960/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9210686/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.7.1566
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!